BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 20688049)

  • 1. Comparison of the pharmacological properties of human and rat histamine H(3)-receptors.
    Schnell D; Strasser A; Seifert R
    Biochem Pharmacol; 2010 Nov; 80(9):1437-49. PubMed ID: 20688049
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histamine H3-receptor-mediated [35S]GTP gamma[S] binding: evidence for constitutive activity of the recombinant and native rat and human H3 receptors.
    Rouleau A; Ligneau X; Tardivel-Lacombe J; Morisset S; Gbahou F; Schwartz JC; Arrang JM
    Br J Pharmacol; 2002 Jan; 135(2):383-92. PubMed ID: 11815373
    [TBL] [Abstract][Full Text] [Related]  

  • 3. G protein-dependent pharmacology of histamine H3 receptor ligands: evidence for heterogeneous active state receptor conformations.
    Krueger KM; Witte DG; Ireland-Denny L; Miller TR; Baranowski JL; Buckner S; Milicic I; Esbenshade TA; Hancock AA
    J Pharmacol Exp Ther; 2005 Jul; 314(1):271-81. PubMed ID: 15821027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Constitutive activity and ligand selectivity of human, guinea pig, rat, and canine histamine H2 receptors.
    Preuss H; Ghorai P; Kraus A; Dove S; Buschauer A; Seifert R
    J Pharmacol Exp Ther; 2007 Jun; 321(3):983-95. PubMed ID: 17332265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High constitutive activity and a G-protein-independent high-affinity state of the human histamine H(4)-receptor.
    Schneider EH; Schnell D; Papa D; Seifert R
    Biochemistry; 2009 Feb; 48(6):1424-38. PubMed ID: 19166345
    [TBL] [Abstract][Full Text] [Related]  

  • 6. No evidence for functional selectivity of proxyfan at the human histamine H3 receptor coupled to defined Gi/Go protein heterotrimers.
    Schnell D; Burleigh K; Trick J; Seifert R
    J Pharmacol Exp Ther; 2010 Mar; 332(3):996-1005. PubMed ID: 19959746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New histamine H(3)-receptor ligands of the proxifan series: imoproxifan and other selective antagonists with high oral in vivo potency.
    Sasse A; Sadek B; Ligneau X; Elz S; Pertz HH; Luger P; Ganellin CR; Arrang JM; Schwartz JC; Schunack W; Stark H
    J Med Chem; 2000 Aug; 43(17):3335-43. PubMed ID: 10966752
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A robust and high-capacity [(35)S]GTPgammaS binding assay for determining antagonist and inverse agonist pharmacological parameters of histamine H(3) receptor ligands.
    Miller TR; Baranowski JL; Estvander BR; Witte DG; Carr TL; Manelli AM; Krueger KM; Cowart MD; Brioni JD; Esbenshade TA
    Assay Drug Dev Technol; 2008 Jun; 6(3):339-49. PubMed ID: 18593375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Two novel and selective nonimidazole histamine H3 receptor antagonists A-304121 and A-317920: I. In vitro pharmacological effects.
    Esbenshade TA; Krueger KM; Miller TR; Kang CH; Denny LI; Witte DG; Yao BB; Fox GB; Faghih R; Bennani YL; Williams M; Hancock AA
    J Pharmacol Exp Ther; 2003 Jun; 305(3):887-96. PubMed ID: 12606603
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distinct pharmacology of rat and human histamine H(3) receptors: role of two amino acids in the third transmembrane domain.
    Ligneau X; Morisset S; Tardivel-Lacombe J; Gbahou F; Ganellin CR; Stark H; Schunack W; Schwartz JC; Arrang JM
    Br J Pharmacol; 2000 Dec; 131(7):1247-50. PubMed ID: 11090094
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutations of Cys-17 and Ala-271 in the human histamine H2 receptor determine the species selectivity of guanidine-type agonists and increase constitutive activity.
    Preuss H; Ghorai P; Kraus A; Dove S; Buschauer A; Seifert R
    J Pharmacol Exp Ther; 2007 Jun; 321(3):975-82. PubMed ID: 17347323
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological profile of histaprodifens at four recombinant histamine H1 receptor species isoforms.
    Strasser A; Striegl B; Wittmann HJ; Seifert R
    J Pharmacol Exp Ther; 2008 Jan; 324(1):60-71. PubMed ID: 17928567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Probing ligand-specific histamine H1- and H2-receptor conformations with NG-acylated Imidazolylpropylguanidines.
    Xie SX; Ghorai P; Ye QZ; Buschauer A; Seifert R
    J Pharmacol Exp Ther; 2006 Apr; 317(1):139-46. PubMed ID: 16394198
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of histamine H(3) receptor function by monovalent ions.
    Schnell D; Seifert R
    Neurosci Lett; 2010 Mar; 472(2):114-8. PubMed ID: 20132865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histamine H3 and dopamine D2 receptor-mediated [35S]GTPgamma[S] binding in rat striatum: evidence for additive effects but lack of interactions.
    Humbert-Claude M; Morisset S; Gbahou F; Arrang JM
    Biochem Pharmacol; 2007 Apr; 73(8):1172-81. PubMed ID: 17306767
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of multiple H3 receptor affinity states utilizing [3H]A-349821, a novel, selective, non-imidazole histamine H3 receptor inverse agonist radioligand.
    Witte DG; Yao BB; Miller TR; Carr TL; Cassar S; Sharma R; Faghih R; Surber BW; Esbenshade TA; Hancock AA; Krueger KM
    Br J Pharmacol; 2006 Jul; 148(5):657-70. PubMed ID: 16715122
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sensitivity of histamine H3 receptor agonist-stimulated [35S]GTP gamma[S] binding to pertussis toxin.
    Clark EA; Hill SJ
    Eur J Pharmacol; 1996 Jan; 296(2):223-5. PubMed ID: 8838460
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histamine H(4) receptor-RGS fusion proteins expressed in Sf9 insect cells: a sensitive and reliable approach for the functional characterization of histamine H(4) receptor ligands.
    Schneider EH; Seifert R
    Biochem Pharmacol; 2009 Sep; 78(6):607-16. PubMed ID: 19464266
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of histamine H1-, H2-, and H3-receptor ligands at the human histamine H4 receptor: identification of 4-methylhistamine as the first potent and selective H4 receptor agonist.
    Lim HD; van Rijn RM; Ling P; Bakker RA; Thurmond RL; Leurs R
    J Pharmacol Exp Ther; 2005 Sep; 314(3):1310-21. PubMed ID: 15947036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel histamine H(3)-receptor antagonists and partial agonists with a non-aminergic structure.
    Nickel T; Bauer U; Schlicker E; Kathmann M; Göthert M; Sasse A; Stark H; Schunack W
    Br J Pharmacol; 2001 Apr; 132(8):1665-72. PubMed ID: 11309237
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.